Colleges, School and Institutes
Willingness to take PhD students
Mathew Coleman's research focusses on the role of protein hydroxylation in the cell biology of tumour cells. He has attracted highly competitive funding support from Cancer Research UK, the MRC, BBSRC and Glaxo Smith Kline. His work on protein hydroxylation has led to patents, and highly cited articles and high impact research and review publications including most recently in Nature, Nature Chemical Biology, PNAS and Molecular Cell.
The Tumour Oxygenase Group always welcomes applications from talented and enthusiastic doctoral researchers to study the role of protein hydroxylation in cancer.